Molecule

Metformin

Metformin hydrochloride

A cheap generic diabetes drug that reshaped the longevity conversation, then partly walked itself back through the TAME trial's slow progress.

Editor approved

Summary Can metformin help healthy people live longer? Show / hide ↓

Metformin is a prescription medicine used for over 60 years to treat type 2 diabetes and high blood sugar. The evidence is strong for diabetes and pre-diabetes, but weak and contested for adults with normal blood sugar. Studies comparing existing patient groups suggested longer lives with metformin, but this type of study cannot prove the medicine caused the benefit. A large trial meant to test whether metformin slows aging has been delayed for over a decade, and animal testing did not extend lifespan. Metformin may also reduce improvements from aerobic exercise in older adults.

What this means for you: Metformin makes sense when prescribed for diabetes or pre-diabetes, but there is not enough evidence to take it solely for longevity. It may even work against some exercise benefits.

conflicting evidence

Evidence tierTier 3, Mixed human evidence, mechanism plausible

Typical dose500-2000 mg/day if prescribed. Longevity-specific dosing is not established.

SafetyGI side effects common. B12 depletion with long-term use. Not for eGFR under 30.

Categoryprescription drug

Last verified2026-08-05

Metformin has been used for over 60 years to treat type 2 diabetes. Its longevity relevance rests on three pillars: it activates AMPK (a metabolic sensor associated with beneficial fasting-like effects), it mildly restricts how efficiently cells use glucose, and observational data suggested diabetics on metformin lived longer than diabetics on other drugs, and sometimes longer than non-diabetic controls.

The headline evidence has weakened over time. The MILES trial found metformin altered gene expression in older adults toward a more youthful pattern. But metformin has also been shown to blunt the aerobic training response in older adults, suggesting it may interfere with exercise adaptation, which is one of the most robust longevity interventions we have.

The TAME trial (Targeting Aging with Metformin), championed by Nir Barzilai, was designed to be the definitive longevity RCT for metformin in non-diabetics. It has been in fundraising and design purgatory for over a decade. Meanwhile, animal data has been mixed: metformin did not extend lifespan in the NIH Interventions Testing Program.

Current honest position: metformin is a reasonable prescription for pre-diabetes or diagnosed type 2 diabetes. As a general longevity supplement for metabolically healthy people, the case is much weaker than it was five years ago. If you exercise seriously, metformin may reduce your training gains.

Metformin is prescription-only in most countries. Sold as a supplement in a few markets under different names, we do not recommend those routes.

Related in the encyclopedia

Further reading